Hepatitis C virus (HCV) is an RNA virus of the Flaviviridae family that is
estimated to have infected 170 million people worldwide. HCV infection can lead to
serious liver disease such as cirrhosis, steatosis, and hepatocellular carcinoma. In
patients, HCV induces an altered redox status and exhibits a high level of genetic
variability, existing as quasispecies. Ethanol consumption has been associated with
increased HCV pathogenesis, elevated HCV titer, increased sequence heterogeneity of
HCV RNA, and decreased efficacy of antiviral treatment, suggesting multiple modes
of interaction between ethanol and HCV. The goal of my studies was to elucidate the
mechanisms of these multiple modes of interaction between alcohol, oxidative stress,
and hepatitis C.
By treating Huh7 human hepatoma cells that naturally express CYP2E1 with
physiological relevant concentrations of ethanol or its metabolites, we determined that
HCV replication was elevated in the context of the complete virus life cycle. This potentiation of HCV replication was dependent on CYP2E1 activity the host
mevalonate pathway, fatty acid synthesis, and an increased NADH/NAD+ ratio. In
contrast, reactive oxygen species rapidly suppressed HCV replication as previously
shown using HCV replicons. These results suggested that lipid metabolism and
alteration of the NADH/NAD+ ratio played an important role in the enhancement of
HCV replication by ethanol.
Finally, we were able to demonstrate that exposing HCV-replicating cells to
ethanol and reactive species elevated both the nucleotide and amino acid substitution
rates of HCV RNA, which were accompanied by oxidative RNA damage. The overall
dN/dS ratio and percentage of sites undergoing positive selection increased with
pronounces changes in the serine/threonine/tyrosine sites. In addition, HCV itself
induced oxidative RNA damage that was exacerbated by ethanol and BSO. Agents
that decreased the RNA damage also reduced the sequence heterogeneity of the HCV
RNA.
Conclusions/Significance: Therefore, ethanol potentiates HCV replication
through the alteration of lipid metabolism and the NADH/NAD+ ratio, which is likely
to contribute to the higher viral titer and pronounced pathogenesis in patients who
drink alcohol. Ethanol may also synergize with virus-induced oxidative/nitrosative
stress to induce RNA damage and likely amplify the error rate of the HCV replicase in
the development of quasispecies, iincreasing the probability of immune evasion and
antiviral resistance.